Unigestion Holding SA Purchases 2,928 Shares of Stryker Co. (NYSE:SYK)

Unigestion Holding SA increased its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 182.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,533 shares of the medical technology company's stock after purchasing an additional 2,928 shares during the period. Unigestion Holding SA's holdings in Stryker were worth $1,687,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of SYK. Norges Bank bought a new position in Stryker during the fourth quarter worth about $1,710,744,000. GAMMA Investing LLC raised its holdings in Stryker by 43,226.8% during the 1st quarter. GAMMA Investing LLC now owns 2,074,922 shares of the medical technology company's stock worth $772,390,000 after buying an additional 2,070,133 shares during the period. Raymond James Financial Inc. bought a new position in Stryker in the fourth quarter valued at approximately $353,394,000. FMR LLC increased its position in shares of Stryker by 10.0% during the fourth quarter. FMR LLC now owns 8,034,844 shares of the medical technology company's stock worth $2,892,946,000 after acquiring an additional 727,850 shares in the last quarter. Finally, Proficio Capital Partners LLC lifted its position in Stryker by 52,520.8% in the 4th quarter. Proficio Capital Partners LLC now owns 596,194 shares of the medical technology company's stock valued at $214,660,000 after acquiring an additional 595,061 shares in the last quarter. Institutional investors own 77.09% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. JMP Securities reiterated a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Truist Financial upped their price objective on Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research note on Monday, May 5th. Sanford C. Bernstein set a $450.00 target price on shares of Stryker in a research note on Monday, May 5th. BTIG Research set a $403.00 target price on shares of Stryker and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Wall Street Zen cut shares of Stryker from a "buy" rating to a "hold" rating in a research note on Thursday, March 6th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, Stryker presently has a consensus rating of "Moderate Buy" and an average target price of $427.30.

Stryker Price Performance

Shares of NYSE:SYK traded up $0.19 during midday trading on Thursday, hitting $382.74. The stock had a trading volume of 904,802 shares, compared to its average volume of 1,331,786. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $146.09 billion, a P/E ratio of 49.32, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. The company's 50-day moving average price is $369.68 and its 200-day moving average price is $376.11. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. The firm had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The company's revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the business posted $2.50 EPS. As a group, equities research analysts predict that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.88%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 5.90% of the company's stock.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.